Literature DB >> 23742863

Inflammation and peripheral 5-HT7 receptors: the role of 5-HT7 receptors in carrageenan induced inflammation in rats.

Abdulmecit Albayrak1, Zekai Halici, Elif Cadirci, Beyzagul Polat, Emre Karakus, Yasin Bayir, Deniz Unal, Mustafa Atasoy, Ahmet Dogrul.   

Abstract

The aim of this study was: (1) to investigate possible role for 5-HT7 receptors in carrageenan induced inflammatory paw oedema in rats; (2) to determine the presence of 5-HT7 receptors in rat paw tissue; (3) to observe the effects of 5-HT7 receptor agonist and antagonist administration on inflammation; and (4) to determine a unique mechanism for inflammatory processes via 5-HT7 receptors. Effects of 5-HT7 receptor agonist, antagonist and indomethacin were investigated in carrageenan induced paw oedema in rats. Blood and tissue samples were collected and evaluated biochemically for serum cytokine levels, tissue oxidant-antioxidant balance and histopathologically for inflammatory cell accumulation. We performed Real Time PCR analyses for tissue 5-HT7 receptor and COX mRNA expressions. The 5-HT7 receptor agonist AS-19 exerted significant anti-inflammatory effect both alone and in combination with indomethacin. Antagonist, SB269970, did not affect inflammation alone but decreased the effects of agonist when co-administered. 5-HT7 mRNA levels were higher in the carrageenan group than healthy control. Carrageenan+indometacin group decreased the mRNA expression of 5-HT7 when compared to carrageenan group. While agonist administration decreased 5-HT7 mRNA expression when compared to carrageenan group. Agonist decreased paw COX expression. Agonist also decreased serum cytokine levels and tissue oxidative stress. In conclusion, this study demonstrated for the first time that 5-HT7 receptors are expressed in rat paw tissue and that this expression responds to inflammatory stimuli. The 5-HT7 receptor may be a promising new therapeutic target for prevention of inflammation and inflammatory disorders and may also provide a new glimpse into inflammation pathophysiology.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-HT(7) receptors; Carrageenan; Cytokine; Inflammation; Oxidative stress

Mesh:

Substances:

Year:  2013        PMID: 23742863     DOI: 10.1016/j.ejphar.2013.05.010

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress.

Authors:  Ali Parlar; Seyfullah Oktay Arslan; Muhammed Fatih Doğan; Saliha Ayşenur Çam; Alper Yalçin; Ebru Elibol; Mehmet Kaya Özer; Fatih Üçkardeş; Halil Kara
Journal:  Exp Ther Med       Date:  2018-09-18       Impact factor: 2.447

2.  The investigation of possible roles of central 5-HT7 receptors in antipyretic effect mechanism of paracetamol in LPS-induced hyperthermia model of mice.

Authors:  Duygu Kose; Elif Cadirci; Zekai Halici; Busra Sirin; Busra Dincer
Journal:  Inflammopharmacology       Date:  2019-07-15       Impact factor: 4.473

Review 3.  Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases.

Authors:  Alejandro Quintero-Villegas; Sergio Iván Valdés-Ferrer
Journal:  Mol Med       Date:  2022-06-20       Impact factor: 6.376

4.  What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury.

Authors:  Erol Akpinar; Zekai Halici; Elif Cadirci; Yasin Bayir; Emre Karakus; Muhammet Calik; Atilla Topcu; Beyzagul Polat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-09       Impact factor: 3.000

5.  Nephroprotective potential of carnitine against glycerol and contrast-induced kidney injury in rats through modulation of oxidative stress, proinflammatory cytokines, and apoptosis.

Authors:  Celalettin S Kunak; Rustem A Ugan; Elif Cadirci; Emre Karakus; Beyzagul Polat; Harun Un; Zekai Halici; Murat Saritemur; Hasan T Atmaca; Adem Karaman
Journal:  Br J Radiol       Date:  2015-11-12       Impact factor: 3.039

6.  5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues.

Authors:  Irfan Cinar; Busra Sirin; Zekai Halici; Saziye Sezin Palabiyik-Yucelik; Erol Akpinar; Elif Cadirci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-02       Impact factor: 3.000

7.  Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors.

Authors:  Małgorzata Kubczak; Aleksandra Szustka; Jerzy Z Błoński; Tomaš Gucký; Małgorzata Misiewicz; Vladmir Krystof; Paweł Robak; Małgorzata Rogalińska
Journal:  Mol Med Rep       Date:  2019-03-05       Impact factor: 2.952

8.  Selective 5-HT7 receptor agonists LP 44 and LP 211 elicit an analgesic effect on formalin-induced orofacial pain in mice.

Authors:  Kadriye Demirkaya; Özlem Martı Akgün; Buğra Şenel; Zeynep Öncel Torun; Melik Seyrek; Enza Lacivita; Marcello Leopoldo; Ahmet Doğrul
Journal:  J Appl Oral Sci       Date:  2016 May-Jun       Impact factor: 2.698

Review 9.  Role of 5-HT7 receptors in the immune system in health and disease.

Authors:  Alejandro Quintero-Villegas; Sergio Iván Valdés-Ferrer
Journal:  Mol Med       Date:  2019-12-31       Impact factor: 6.354

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.